Skip to main content

Table 2 Univariate Survival Analysis According To Clinical Characteristics

From: Fibrinogen: a novel predictor of responsiveness in metastatic melanoma patients treated with bio-chemotherapy: IMI (italian melanoma inter-group) trial

Clinical Variable No. Of patients Median Survival, Months (CI) Odds Ratio Log-Rank P
Liver Disease     
   Yes 114 12 (9.7–14.6) 2.4 (1.64–3.53)  
   No 62 6.3 (4.8–8.6)   0.0001
PS     
   0 119 1.6 (9.2–14.4) 1.85 (1.27–2.67) 0.001
   1–2 57 6.9 (4.7–10.1)   
Age     
   <60 years 99 9.2 (7.3–12.7) 0.97 (0.7–1.4) 0.85
   ≥ 60 years 77 10.7 (8.2–13.2)   
Sex     
   Male 105 9.3 (7.8–11) 0.78 (0.54–1.12) 0.178
   Female 71 12 (7.9–14.6)